These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32831192)
1. A fourteen-lncRNA risk score system for prognostic prediction of patients with non-small cell lung cancer. Song JY; Li XP; Qin XJ; Zhang JD; Zhao JY; Wang R Cancer Biomark; 2020; 29(4):493-508. PubMed ID: 32831192 [TBL] [Abstract][Full Text] [Related]
2. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581 [TBL] [Abstract][Full Text] [Related]
3. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China. Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367 [TBL] [Abstract][Full Text] [Related]
4. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer. Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164 [TBL] [Abstract][Full Text] [Related]
5. A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer. Lin T; Fu Y; Zhang X; Gu J; Ma X; Miao R; Xiang X; Niu W; Qu K; Liu C; Wu Q Aging (Albany NY); 2018 Sep; 10(9):2356-2366. PubMed ID: 30205363 [TBL] [Abstract][Full Text] [Related]
6. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer. Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477 [TBL] [Abstract][Full Text] [Related]
7. Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer. Xu Q; Liu T; Wang J Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360316 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma. Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273 [TBL] [Abstract][Full Text] [Related]
9. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma. Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature. Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988 [TBL] [Abstract][Full Text] [Related]
11. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer. Han P; Zhao J; Gao L J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140 [TBL] [Abstract][Full Text] [Related]
12. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma. Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347 [TBL] [Abstract][Full Text] [Related]
13. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
14. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer. Fan Q; Liu B Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307 [TBL] [Abstract][Full Text] [Related]
15. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. Sun J; Zhang Z; Bao S; Yan C; Hou P; Wu N; Su J; Xu L; Zhou M J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32041817 [TBL] [Abstract][Full Text] [Related]
16. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA. Han Y; Dong Z; Xing Y; Zhan Y; Zou J; Wang X BMC Pulm Med; 2023 Dec; 23(1):511. PubMed ID: 38102594 [TBL] [Abstract][Full Text] [Related]
17. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC. Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer. Zhou M; Sun Y; Sun Y; Xu W; Zhang Z; Zhao H; Zhong Z; Sun J Oncotarget; 2016 May; 7(22):32433-48. PubMed ID: 27074572 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Lin L; Gu ZT; Chen WH; Cao KJ Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]